NPs Basic Information

Name
3-Nitropropionic acid
Molecular Formula C3H5NO4
IUPAC Name*
3-nitropropanoic acid
SMILES
C(C[N+](=O)[O-])C(=O)O
InChI
InChI=1S/C3H5NO4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)
InChIKey
WBLZUCOIBUDNBV-UHFFFAOYSA-N
Synonyms
3-nitropropionic acid; 3-Nitropropanoic acid; 504-88-1; Bovinocidin; Hiptagenic acid; beta-Nitropropionic acid; 3-Nitropropionate; Propanoic acid, 3-nitro-; Propionic acid, 3-nitro-; 3-NP acid; beta-Nitropropanoic acid; NCI-C03076; NSC 64266; 3-nitro-propionic acid; BOVINOCIDIN (3-nitropropionic acid); NITROPROPIONIC ACID, BETA; .beta.-Nitropropionic acid; 3-NPA; beta-Nitropropanoate; 3-Nitroporpionic Acid; CHEBI:16348; QY4L0FOX0D; BNP; CHEMBL451226; NSC64266; NSC-64266; DSSTox_CID_982; DSSTox_RID_75904; 3-nitro-1-propionate; DSSTox_GSID_20982; CAS-504-88-1; CCRIS 454; HSDB 4147; Nitropropionic aci, beta; SR-01000076030; EINECS 208-003-0; UNII-QY4L0FOX0D; BRN 1759889; MFCD00007406; b-nitropropionic acid; Spectrum_001674; 3-Nitro-Propanoic acid; SpecPlus_000692; beta -nitropropionic acid; Nitropropionic acid, 3-; Spectrum2_000876; Spectrum3_000993; Spectrum4_001119; Spectrum5_001895; Lopac-N-5636; WLN: WN2VQ; Nitropropionic acid, .beta.; 3-Nitropropionic acid, 8CI; Lopac0_000838; SCHEMBL70072; BSPBio_002685; KBioGR_001598; KBioSS_002154; 4-02-00-00771 (Beilstein Handbook Reference); MLS001066410; 3-Nitropropionic acid, 97%; DivK1c_006788; SPECTRUM1504206; SPBio_000951; 3-NP; DTXSID1020982; 3-Nitropropionic acid, >=97%; BDBM82201; KBio1_001732; KBio2_002154; KBio2_004722; KBio2_007290; KBio3_001905; HMS2235N03; HMS3262H17; HMS3369D16; HMS3865D03; ZINC895862; Propanoic acid, 3-nitro- (9CI); BCP15066; Tox21_202460; Tox21_303007; Tox21_500838; BDBM50480795; CCG-40325; s3652; 3-NITROPROPIONIC ACID [HSDB]; AKOS006221915; AKOS015833440; 504-88-1 (FREE ACID); CS-W013591; HY-W012875; LP00838; SDCCGMLS-0066769.P001; SDCCGSBI-0050815.P003; 3-Nitropropanoic acid; 3-nitropropanoate; NCGC00015744-01; NCGC00015744-02; NCGC00015744-03; NCGC00015744-04; NCGC00015744-05; NCGC00015744-06; NCGC00015744-07; NCGC00015744-11; NCGC00094169-01; NCGC00094169-02; NCGC00094169-03; NCGC00094169-04; NCGC00256389-01; NCGC00260009-01; NCGC00261523-01; SMR000471863; 3-Nitropropionic acid - CAS 504-88-1; DB-008848; EU-0100838; FT-0632243; C05669; F17743; N 5636; 2-(4-Nitrophenylamino)thiazole-4-carboxylicacid; Q223104; SR-01000076030-1; SR-01000076030-5
CAS 504-88-1
PubChem CID 1678
ChEMBL ID CHEMBL451226
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organic 1,3-dipolar compo
      • Class: Allyl-type 1,3-dipolar or
        • Subclass: Organic nitro compounds
          • Direct Parent: C-nitro compounds

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 119.08 ALogp: -0.5
HBD: 1 HBA: 4
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 83.1 Aromatic Rings: 0
Heavy Atoms: 8 QED Weighted: 0.424

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.44 MDCK Permeability: 0.00177134
Pgp-inhibitor: 0.001 Pgp-substrate: 0.003
Human Intestinal Absorption (HIA): 0.015 20% Bioavailability (F20%): 0.002
30% Bioavailability (F30%): 0.002

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.215 Plasma Protein Binding (PPB): 34.72%
Volume Distribution (VD): 0.273 Fu: 68.18%

ADMET: Metabolism

CYP1A2-inhibitor: 0.01 CYP1A2-substrate: 0.069
CYP2C19-inhibitor: 0.042 CYP2C19-substrate: 0.056
CYP2C9-inhibitor: 0.014 CYP2C9-substrate: 0.851
CYP2D6-inhibitor: 0.014 CYP2D6-substrate: 0.166
CYP3A4-inhibitor: 0.011 CYP3A4-substrate: 0.024

ADMET: Excretion

Clearance (CL): 6.987 Half-life (T1/2): 0.857

ADMET: Toxicity

hERG Blockers: 0.01 Human Hepatotoxicity (H-HT): 0.843
Drug-inuced Liver Injury (DILI): 0.072 AMES Toxicity: 0.801
Rat Oral Acute Toxicity: 0.227 Maximum Recommended Daily Dose: 0.149
Skin Sensitization: 0.526 Carcinogencity: 0.099
Eye Corrosion: 0.975 Eye Irritation: 0.983
Respiratory Toxicity: 0.083
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000677 0.400 D06VNK 0.379
ENC000018 0.400 D0EP8X 0.357
ENC001187 0.394 D0Y7ZD 0.344
ENC000062 0.379 D0O4GY 0.333
ENC000639 0.357 D00ENY 0.324
ENC000735 0.344 D0R3QY 0.303
ENC000445 0.333 D0FD0H 0.294
ENC000315 0.323 D0M8AB 0.292
ENC000643 0.323 D0Z0MG 0.262
ENC000795 0.297 D02FLB 0.261
*Note: the compound similarity was calculated by RDKIT.